SpringWorks Therapeutics (SWTX)
(Delayed Data from NSDQ)
$32.13 USD
-0.75 (-2.28%)
Updated Sep 24, 2024 03:59 PM ET
After-Market: $32.12 -0.01 (-0.03%) 4:24 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.76 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | 51.79% |
ABR | 1.00 |
Earnings ESP
|
0.79% |
---|---|
Current Year | -3.36 |
Next Year | -1.87 |
EPS (TTM) | -4.43 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 53.68M | 64.86M | 199.28M | 396.62M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 57.76M | 72.67M | 210.64M | 454.83M |
Low Estimate | 46.48M | 52.65M | 179.87M | 311.48M |
Year ago Sales | 0.00M | 5.45M | 5.45M | 199.28M |
Year over Year Growth Est. | NA | 1,090.06% | 3,558.49% | 99.03% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.76 | -0.68 | -3.36 | -1.87 |
# of Estimates | 5 | 5 | 6 | 6 |
Most Recent Consensus | -0.60 | -0.50 | -2.83 | -1.92 |
High Estimate | -0.60 | -0.50 | -2.83 | 0.11 |
Low Estimate | -0.95 | -0.96 | -4.32 | -3.33 |
Year ago EPS | -1.27 | -1.44 | -5.15 | -3.36 |
Year over Year Growth Est. | 40.16% | 52.78% | 34.76% | 44.10% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 5 | 4 | 6 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 0 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.76 | -0.68 | -3.36 | -1.87 |
7 Days Ago | -0.76 | -0.68 | -3.36 | -1.87 |
30 Days Ago | -0.75 | -0.67 | -3.34 | -1.87 |
60 Days Ago | -1.02 | -0.96 | -4.62 | -3.24 |
90 Days Ago | -1.02 | -0.96 | -4.62 | -3.24 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.75 | -0.64 | -3.11 | -1.42 |
Zacks Consensus Estimate | -0.76 | -0.68 | -3.36 | -1.87 |
Earnings ESP | 0.79% | 6.43% | 7.30% | 24.47% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.54 | -1.18 | -1.44 | -1.27 | NA |
Estimate | -1.12 | -1.17 | -1.25 | -1.31 | NA |
Difference | 0.58 | -0.01 | -0.19 | 0.04 | 0.11 |
Surprise | 51.79% | -0.85% | -15.20% | 3.05% | 9.70% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more